Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The renal dialysis market has been steadily growing due to several important reasons. One of the main drivers is the increasing number of people with chronic kidney disease (CKD). Chronic kidney disease is becoming more common due to factors such as diabetes, hypertension, and an aging population. For example, the Centres for Disease Control and Prevention (US) predicts that by 2023, 35.5 million US adults, or 14% (more than 1 in 7), will have CKD. Similarly, a review article published in 2022 stated that chronic kidney disease affects over 10% of the global population, which is more than 800 million people. The growing awareness about CKD and the availability of better diagnostic tools have also helped in the early detection and diagnosis of the disease, leading to timely interventions like renal dialysis. Advances in dialysis machines, filters, and patient monitoring systems have also improved the overall treatment experience and outcomes.
In addition to the increasing prevalence of CKD, the expanding elderly population, along with higher healthcare spending and favorable reimbursement policies, have made renal dialysis services more accessible to a larger part of the population. Ongoing research and development efforts have resulted in the introduction of innovative dialysis methods and therapies, further fueling market growth. Furthermore, dialysis service providers have expanded their operations into emerging markets, making dialysis services more available in underserved regions.
The growth of the renal dialysis market has created an environment where essential treatments for patients with CKD and end-stage renal disease are more widely available. The expansion of dialysis services into underserved regions has helped in providing vital treatments to those who previously had limited access. This has positively impacted the market's expansion, ensuring that more individuals receive the necessary care and support for their kidney-related health issues.
Impact of Technological Advancements on Renal Dialysis
Moreover, advancements in technology have played a crucial role in improving the effectiveness and accessibility of renal dialysis treatments. Innovations in dialysis machines, filters, and patient monitoring systems have enhanced the overall patient experience and treatment outcomes. These technological advancements have contributed to a more efficient and comfortable dialysis process, ultimately benefiting the patients undergoing treatment.
In conclusion, the renal dialysis market has experienced significant growth due to the increasing prevalence of chronic kidney disease, advancements in technology, expanding elderly population, and efforts to make dialysis services more accessible. This growth has created an environment where essential treatments for individuals with CKD and end-stage renal disease are more widely available, positively impacting the lives of many. As the market continues to evolve, it is expected to play a crucial role in meeting the growing demand for renal dialysis treatments and supporting the well-being of individuals with kidney-related health issues.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|---|
| Market Size Value In 2022 | USD 20.2 Billion |
| Market Size Value In 2023 | USD 21.57Billion Billion |
| Growth Rate | 6.80% (2023-2032) |
Europe CRO Market Highlights:
Europe CRO Market Overview
Europe CRO Market Size was valued at USD 20.2 Billion in 2022. The CRO market industry is projected to grow from USD 21.57 billion in 2023 to USD 36.15 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.80% during the forecast period (2023 - 2032). Increased health concerns and challenges have led to more expensive operations, and more bariatric procedures are the key market drivers enhancing the market growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
CRO Market Trends
- Growing demand for virtual and decentralized clinical trials is driving the market growth
The demand for virtual and decentralized clinical trials has increased at the fastest Market CAGR. The implementation of remote monitoring and patient-centric approaches has been expedited due to the COVID-19 pandemic, resulting in a decreased necessity for in-person site visits. This phenomenon improves the efficiency of patient recruitment, retention, and data acquisition, thereby increasing the accessibility and inclusivity of clinical trials. By integrating digital technologies, telemedicine, and data analytics, CROs are fostering a clinical trial environment that is more adaptable and robust.
Furthermore, pragmatic clinical trials and real-world evidence (RWE) are gaining increasing attention. Various stakeholders, such as regulatory bodies and healthcare providers, are acknowledging the value of integrating real-world data with conventional clinical trial data. This integration aims to enhance comprehension of treatment efficacy and safety across diverse patient populations. Clinical Research Organizations (CROs) are assuming a crucial function in the development and implementation of pragmatic trials that mirror routine clinical practice. This enables CROs to offer insights that extend beyond the controlled setting of conventional trials. Consistent with the industry's overarching transition towards research methodologies that prioritize patient outcomes and are more patient-centric, this trend impacts the strategic trajectory of CROs that operate within the European market. Thus driving the CRO market revenue.
CRO Market Segment Insights
CRO Service Type Insights
The Europe CRO market segmentation, based on Service Type, includes early Phase Development Services, Clinical, Laboratory Services, and Others. Clinical services represent the most substantial sector within the European CRO market, primarily propelled by the escalating intricacies associated with clinical trials. Pharmaceutical and biotechnology companies are increasingly delegating clinical trial operations to CROs in order to capitalize on their specialized knowledge, expedite trial schedules, and effectively manage regulatory obligations. This demand for all-encompassing clinical services drives the expansion of this sector within the European CRO industry.
CRO Application Insights
The Europe CRO market segmentation, based on Application, includes Oncology, Neurology, Cardiology, Infectious Disease, Metabolic Disorder, Renal/Nephrology, and Others. The European CRO market is witnessing the emergence of oncology as the largest segment, driven by the growing emphasis on cancer research and the elevated incidence of oncological disorders. Pharmaceutical companies utilize CROs due to the intricate nature of oncology trials, which necessitates specialized knowledge and a strong approach to patient recruitment. As a result, this sector experienced significant expansion.
CRO Service End-user Insights
The Europe CRO market segmentation, based on End-users, includes Pharmaceutical and biotech Companies, Medical Device Companies, Academic and Research Institutes, and Others. Pharmaceutical and biotechnology companies constitute the largest segment of the European CRO market, which is being driven by the increasing trend of outsourcing. In order to streamline research processes, reduce expenses, and expedite drug development schedules, these organizations pursue CRO expertise. By harnessing external capabilities, they are able to outsource, which guarantees a concentration on fundamental capabilities and improves the overall efficacy of research and development undertakings.
Figure 1: Europe CRO Market, by End User, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
CRO Regional Insights
By region, the study provides market insights into Germany, France, the UK, Italy, Spain and the rest of Europe. Germany dominates the European market due to its strong pharmaceutical and biotechnology industries, sophisticated research infrastructure, and leadership in innovation. The United Kingdom is the most rapidly expanding region, driven by technological advancements, a supportive regulatory environment, and a dynamic life sciences ecosystem. The CRO market is expanding at a faster rate in France, the second-largest region, due to its robust pharmaceutical industry, research excellence, and rising outsourcing trends.
Figure 2: EUROPE CRO MARKET SHARE BY REGION 2022 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
CRO Key Market Players & Competitive Insights
Leading market players in the European CRO market engage in mergers and strategic collaborations to combat the intense competition. CROs are emphasizing broadening their service portfolios and expanding their geographic reach in response to the growing demand for specialized services and other market developments. In the swiftly evolving European CRO market, companies are striving to provide comprehensive solutions to pharmaceutical and biotechnology partners, thereby intensifying competition and cultivating a dynamic environment.
Key Companies in the CRO market include
- Pharmaceutical Product Development, LLC (Thermo Fisher Scientific ) (U.S.)
- Medpace Holdings, Inc. (U.S.)
- Parexel International Corporation (Ireland)
- IQVIA (U.S.)
- Laboratory Corporation of America Holdings (U.S.)
- Charles River Laboratories (U.S.)
- PHASTAR (U.K.)
- Oy 4Pharma Ltd (Finland)
- PSI (Switzerland)
- Icon plc (Ireland)
CRO Market Segmentation
CRO Service Type Outlook
- Early Phase Development Services
- Clinical
- Laboratory Service
- Others
CRO Application Outlook
- Oncology
- Neurology
- Cardiology
- Infectious Disease
- Metabolic Disorder
- Renal/Nephrology
- Others
CRO End-user Outlook
- Pharmaceutical & Biotech Companies
- Medical Device Companies
- Academic & Research Institutes
- Others
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
